Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection.
Amaral EP, Foreman TW, Namasivayam S, Hilligan KL, Kauffman KD, Barbosa Bomfim CC, Costa DL, Barreto-Duarte B, Gurgel-Rocha C, Santana MF, Cordeiro-Santos M, Du Bruyn E, Riou C, Aberman K, Wilkinson RJ, Barber DL, Mayer-Barber KD, Andrade BB, Sher A. Amaral EP, et al. J Exp Med. 2022 Nov 7;219(11):e20220504. doi: 10.1084/jem.20220504. Epub 2022 Sep 7. J Exp Med. 2022. PMID: 36069923 Free PMC article.
Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.
Peetluk LS, Rebeiro PF, Cordeiro-Santos M, Kritski A, Andrade BB, Durovni B, Calvacante S, Arriaga MB, Turner MM, Figueiredo MC, Rolla VC, Sterling TR. Peetluk LS, et al. J Infect Dis. 2020 Apr 7;221(9):1416-1424. doi: 10.1093/infdis/jiz595. J Infect Dis. 2020. PMID: 31724035 Free PMC article.
Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study).
Safe IP, Lacerda MVG, Printes VS, Praia Marins AF, Rebelo Rabelo AL, Costa AA, Tavares MA, Jesus JS, Souza AB, Beraldi-Magalhães F, Neves CP, Monteiro WM, Sampaio VS, Amaral EP, Gomes RS, Andrade BB, Cordeiro-Santos M. Safe IP, et al. PLoS One. 2020 Jun 26;15(6):e0235381. doi: 10.1371/journal.pone.0235381. eCollection 2020. PLoS One. 2020. PMID: 32589648 Free PMC article. Clinical Trial.
Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil.
Arriaga MB, Amorim G, Queiroz ATL, Rodrigues MMS, Araújo-Pereira M, Nogueira BMF, Souza AB, Rocha MS, Benjamin A, Moreira ASR, de Oliveira JG, Figueiredo MC, Turner MM, Alves K, Durovni B, Lapa-E-Silva JR, Kritski AL, Cavalcante S, Rolla VC, Cordeiro-Santos M, Sterling TR, Andrade BB; RePORT Brazil consortium. Arriaga MB, et al. Int J Infect Dis. 2021 Feb;103:110-118. doi: 10.1016/j.ijid.2020.11.140. Epub 2020 Nov 14. Int J Infect Dis. 2021. PMID: 33197582 Free PMC article.
Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial.
Safe IP, Amaral EP, Araújo-Pereira M, Lacerda MVG, Printes VS, Souza AB, Beraldi-Magalhães F, Monteiro WM, Sampaio VS, Barreto-Duarte B, Andrade AMS, Spener-Gomes R, Costa AG, Cordeiro-Santos M, Andrade BB. Safe IP, et al. Front Immunol. 2021 Feb 4;11:602589. doi: 10.3389/fimmu.2020.602589. eCollection 2020. Front Immunol. 2021. PMID: 33613521 Free PMC article. Clinical Trial.
The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts.
Arriaga MB, Rocha MS, Nogueira BMF, Nascimento V, Araújo-Pereira M, Souza AB, Andrade AMS, Costa AG, Gomes-Silva A, Silva EC, Figueiredo MC, Turner MM, Durovni B, Lapa-E-Silva JR, Kritski AL, Cavalcante S, Rolla VC, Cordeiro-Santos M, Sterling TR, Andrade BB. Arriaga MB, et al. J Infect Dis. 2021 Dec 15;224(12):2064-2072. doi: 10.1093/infdis/jiab264. J Infect Dis. 2021. PMID: 34008010 Free PMC article.
A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.
Peetluk LS, Rebeiro PF, Ridolfi FM, Andrade BB, Cordeiro-Santos M, Kritski A, Durovni B, Calvacante S, Figueiredo MC, Haas DW, Liu D, Rolla VC, Sterling TR; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil Network. Peetluk LS, et al. Clin Infect Dis. 2022 Mar 23;74(6):973-982. doi: 10.1093/cid/ciab598. Clin Infect Dis. 2022. PMID: 34214166 Free PMC article.
Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study.
Carvalho ACC, Amorim G, Melo MGM, Silveira AKA, Vargas PHL, Moreira ASR, Rocha MS, Souza AB, Arriaga MB, Araújo-Pereira M, Figueiredo MC, Durovni B, Lapa-E-Silva JR, Cavalcante S, Rolla VC, Sterling TR, Cordeiro-Santos M, Andrade BB, Silva EC, Kritski AL; RePORT Brazil consortium. Carvalho ACC, et al. Front Immunol. 2021 Jul 2;12:661934. doi: 10.3389/fimmu.2021.661934. eCollection 2021. Front Immunol. 2021. PMID: 34276654 Free PMC article.
86 results